Tg Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tg Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.2M | 186k | 17.08 |
| 2023-09-30 | $1.6M | 188k | 8.36 |
| 2023-06-30 | $4.5M | 182k | 24.84 |
| 2023-03-31 | $2.2M | 147k | 15.04 |
| 2022-12-31 | $1.6M | 138k | 11.83 |
| 2022-09-30 | $812k | 137k | 5.92 |
| 2022-06-30 | $520k | 122k | 4.25 |
| 2022-03-31 | $1.2M | 128k | 9.49 |
| 2021-12-31 | $2.3M | 121k | 18.98 |
| 2021-09-30 | $4.0M | 119k | 33.31 |
| 2021-06-30 | $4.6M | 118k | 38.80 |
| 2021-03-31 | $18M | 382k | 48.20 |
| 2020-12-31 | $10M | 193k | 51.95 |
| 2020-09-30 | $4.4M | 163k | 26.77 |
| 2020-06-30 | $9.7M | 496k | 19.48 |
| 2020-03-31 | $1.3M | 128k | 9.85 |
| 2019-12-31 | $1.8M | 161k | 11.09 |
| 2019-09-30 | $841k | 77k | 10.99 |
| 2019-06-30 | $429k | 50k | 8.66 |
| 2019-03-31 | $599k | 60k | 10.00 |
| 2018-12-31 | $202k | 49k | 4.10 |
| 2018-09-30 | $242k | 43k | 5.59 |
| 2018-06-30 | $737k | 56k | 13.07 |
| 2018-03-31 | $1.4M | 95k | 14.20 |
| 2017-12-31 | $542k | 67k | 8.10 |
| 2017-09-30 | $3.9M | 274k | 14.08 |
| 2017-06-30 | $2.0M | 201k | 10.05 |
| 2017-03-31 | $1.7M | 144k | 11.67 |
| 2016-12-31 | $251k | 54k | 4.68 |
| 2016-09-30 | $939k | 121k | 7.78 |
| 2016-06-30 | $1.9M | 309k | 6.05 |
| 2016-03-31 | $340k | 40k | 8.52 |
| 2015-12-31 | $419k | 35k | 11.90 |
| 2015-09-30 | $205k | 21k | 9.88 |
| 2015-06-30 | $1.3M | 81k | 16.59 |
| 2015-03-31 | $401k | 26k | 15.47 |
| 2014-12-31 | $713k | 45k | 15.83 |
| 2014-09-30 | $264k | 25k | 10.69 |
| 2014-06-30 | $355k | 39k | 9.20 |
| 2013-12-31 | $42k | 11k | 3.80 |